Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.940
-0.010 (-0.51%)
Sep 17, 2025, 4:00 PM EDT - Market closed
Milestone Pharmaceuticals Employees
Milestone Pharmaceuticals had 33 employees as of December 31, 2024. The number of employees decreased by 14 or -29.79% compared to the previous year.
Employees
33
Change (1Y)
-14
Growth (1Y)
-29.79%
Revenue / Employee
n/a
Profits / Employee
-$1,682,697
Market Cap
189.94M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 33 | -14 | -29.79% |
| Dec 31, 2023 | 47 | 8 | 20.51% |
| Dec 31, 2022 | 39 | 10 | 34.48% |
| Dec 31, 2021 | 29 | 1 | 3.57% |
| Dec 31, 2020 | 28 | -2 | -6.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MIST News
- 4 weeks ago - Milestone® Pharmaceuticals to Present at Upcoming Conferences - GlobeNewsWire
- 5 weeks ago - Milestone Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Regulatory and Corporate Update - GlobeNewsWire
- 2 months ago - Milestone Pharmaceuticals Remains A Buying Opportunity Despite Recent Dilution - Seeking Alpha
- 2 months ago - Crude Oil Rises Sharply; Milestone Pharmaceuticals Shares Plunge - Benzinga
- 2 months ago - Milestone Pharmaceuticals Announces Pricing of $52.5 Million Public Offering of Common Shares, Pre-Funded Warrants, Series A Common Warrants and Series B Common Warrants - GlobeNewsWire
- 2 months ago - Milestone Pharmaceuticals Announces Proposed Public Offering - GlobeNewsWire
- 2 months ago - Milestone Pharmaceuticals Announces FDA Acceptance of the Company's Response to the CRL for CARDAMYST™ (etripamil) Nasal Spray - GlobeNewsWire
- 2 months ago - Watch Milestone Pharmaceuticals For (Likely) Upcoming FDA Approval For Cardamyst - Seeking Alpha